Article
Nearly 80% of cystic fibrosis heterozygotes and 64% of couples at risk may be detected through a unique screening of four mutations by ASO reverse dot blot.
Genomics - 1 Dec 1991
Serre J L, Taillandier A, Mornet E, Simon-Bouy B, Boué J, Boué A
Abstract excerpt
A technique allowing the simultaneous screening of the four main CF mutations in the French population (delta F508, delta I507, G542X, S549N) has been developed by means of allele sequence-specific oligonucleotide (ASO) reverse dot blot. Using a strategy proposed by R. K. Saïki et al. (1989, Proc. Natl. Acad. Sci. USA 86: 6230-6234) for HLA-DQA, the seven ASOs for normal and mutant CF alleles were given a...
Topics
- Alleles
- Base Sequence
- Cystic Fibrosis
- DNA
- Deoxyribonucleotides
- France
- Genetic Carrier Screening
- Genetic Testing
- Humans
- Immunoblotting
- Molecular Sequence Data
